Opal Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-6
Closed -$681 468
2024
Q2
$681 Buy
+6
New +$759 ﹤0.01% 1135
2022
Q4
Sell
-6,387
Closed -$514K 127
2022
Q3
$514K Sell
6,387
-31
-0.5% -$2.63K 0.38% 41
2022
Q2
$478K Buy
6,418
+22
+0.3% +$2.01K 0.32% 44
2022
Q1
$818K Buy
6,396
+588
+10% +$64.3K 0.71% 20
2021
Q4
$780K Buy
+5,808
New +$835K 0.49% 36

Other funds holding DXCM

Opal Wealth Advisors's DXCM Position: Q3 2024 in Review

Opal Wealth Advisors sold out of DexCom (DXCM) in Q3 2024, closing a stake of 6 shares — an estimated $681 sold.

Opal Wealth Advisors first reported a position in DXCM in Q4 2021 and held it in 5 quarters. The position peaked at $818K in Q1 2022. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • Opal Wealth Advisors reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • Opal Wealth Advisors sold 6 DexCom shares in Q3 2024, an estimated $681.
  • Opal Wealth Advisors first reported a position in DexCom in Q4 2021 and held it in 5 quarters.
  • Opal Wealth Advisors's DexCom position peaked at $818K in Q1 2022.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Opal Wealth Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.